Complementary Value of MRD Assessments by NGS and MFC for the Study of Hematologic Malignancies
1:01:18
2022 Jan26 Webinar
54:49
Multiparameter Approach to CLL Diagnosis, Prognostic Biomarker Assessment, and MRD Monitoring
59:56
De novo design of miniprotein-based natural killer cell engagers
58:20
Think Fast, Talk Smart: Communication Techniques
57:19
Introduction to Orthobiologic Therapies | National Fellow Online Lecture Series
47:55
Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing
1:04:08
LACNETS • "High Grade Neuroendocrine Neoplasms (NEN)" with Dr. Jason Starr • May 2023
36:02